While mesothelioma is a problem in all states, the specific incident rate for Delaware is 1.5 / 100,000. This is above the average rate of 1.1 / 100,000. Click on the tabs below to find mesothelioma and asbestos research in DE, recent DE mesothelioma-related court cases, mesothelioma specialists in DE and potential asbestos hotspots in Delaware.

[doptabs]
[doptab title=”Overview”]

Delaware Mesothelioma Info

By clicking on the above tabs, you will find information on mesothelioma specific to the state of Delaware

Delaware Research and Clinical Trials

This is a partial list of scientific or medical grants in your state for research into mesothelioma and related illnesses.

Delaware Doctors and Hospitals

This is a partial list of hospitals and physicians that reportedly treat mesothelioma patients in your state.

Delaware Cases

This is a partial list of relevant court cases on mesothelioma in your state.

Disclaimer: Inclusion on this directory does not constitute endorsement by Cancer Monthly, Inc. All physicians who appear in this section do so based on their own expression of interest in the fields of mesothelioma treatment. Cancer Monthly, Inc. has not verified the competence, professional credentials, business practices or validity of the expressed interests of these physicians. Cancer Monthly makes no recommendation of any physician on this list and makes no suggestion that any such physician will cure or prevent any disease. Those consulting a physician on this list should approach the consultation exactly as they would with any other unknown physician.

[/doptab]
[doptab title=”Treatment and Research”]

Research

Clinical Trials

[dopaccordions]
[dopaccordion title=”Active, not recruiting Sorafenib in Treating Patients With Malignant Mesothelioma” icon=27 activeicon=28]

Condition: Malignant Mesothelioma
Intervention: Drug: sorafenib tosylate
More Information

[/dopaccordion]
[dopaccordion title=”Active, not recruiting Pemetrexed Disodium and Either Gemcitabine or Carboplatin in Treating Patients With Advanced Malignant Pleural Mesothelioma” icon=27 activeicon=28]

Condition: Malignant Mesothelioma
Intervention: Drug: carboplatin; Drug: gemcitabine hydrochloride; Drug: pemetrexed disodium
More Information

[/dopaccordion]

[dopaccordion title=”Active, not recruiting Dasatinib in Treating Patients With Previously Treated Malignant Mesothelioma” icon=27 activeicon=28]

Condition: Malignant Mesothelioma
Intervention: Drug: dasatinib; Other: immunoenzyme technique; Other: immunohistochemistry staining method; Other: laboratory biomarker analysis
More Information

[/dopaccordion]
[dopaccordion title=”Completed Gefitinib in Treating Patients With Malignant Mesothelioma” icon=27 activeicon=28]

Condition: Malignant Mesothelioma
Intervention: Drug: gefitinib
More Information

[/dopaccordion]
[dopaccordion title=”Active, not recruiting Capecitabine in Treating Patients With Malignant Mesothelioma” icon=27 activeicon=28]

Condition: Malignant Mesothelioma
Intervention: Drug: capecitabine
More Information

[/dopaccordion]
[dopaccordion title=”Active, not recruiting PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma” icon=27 activeicon=28]

Condition: Malignant Mesothelioma
Intervention: Drug: vatalanib
More Information

[/dopaccordion]
[dopaccordion title=”Suspended Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery” icon=27 activeicon=28]

Condition: Malignant Mesothelioma
Intervention: Drug: everolimus
More Information

[/dopaccordion]
[dopaccordion title=”Recruiting An Efficacy Study of MORAb-009 in Subjects With Pleural Mesothelioma” icon=27 activeicon=28]

Condition: Malignant Pleural Mesothelioma
Intervention: Drug: MORAb-009 by IV on Days 1 and 8 every 21 days for 6 cycles.
More Information

[/dopaccordion]
[/dopaccordions]
[/doptab]
[doptab title=”Doctors and Hospital”]

Hospitals and Cancer Centers

We do not have any doctors or cancer centers for this state at the moment.

[/doptab]
[doptab title=”Cases”]

GMC v. Grenier
Nos. 453, 2007 And 578, 2007 (Consolidated), SUPREME COURT OF DELAWARE, June 15, 2009, Submitted, August 24, 2009, Decided

Riedel v. ICI Ams. Inc.
No. 156, 2008, SUPREME COURT OF DELAWARE, December 10, 2008, Submitted, March 4, 2009, Decided

GMC v. Grenier
No. 453, 2007 & 578, 2007, SUPREME COURT OF DELAWARE, October 29, 2008, Submitted, February 4, 2009, Decided

Roca v. E.I. du Pont de Nemours & Co.
No. 640, 2002 , SUPREME COURT OF DELAWARE, November 4, 2003, Submitted , January 30, 2004, Decided

Viking Pump, Inc. v. Century Indem. Co.
C.A. No. 1465-VCS, COURT OF CHANCERY OF DELAWARE, NEW CASTLE, August 7, 2009, Submitted, October 14, 2009, Decided

Scaife v. Astrazeneca LP
C.A. NO. 06C-04-218 SER, SUPERIOR COURT OF DELAWARE, NEW CASTLE, March 27, 2009, Submitted, June 9, 2009, Decided

Grenier v. GMC (In re Asbestos Litig.)
C.A. No. 05C-11-257 ASB, SUPERIOR COURT OF DELAWARE, NEW CASTLE, February 4, 2009, Decided

Lagrone v. American Mortell Corp.
C.A. No. 04C-10-116-ASB, C.A. No. 07C-12-019-JRS, SUPERIOR COURT OF DELAWARE, NEW CASTLE, June 20, 2008, Submitted, September 4, 2008, Decided

In re Asbestos Litig.
C.A. NO. 04C-07-099-ASB, SUPERIOR COURT OF DELAWARE, NEW CASTLE, June 26, 2007, Submitted, December 21, 2007, Decided

Lagrone v. AADG, Inc. (In re Asbestos Litig.)
C.A. No. 04C-10-116-ASB, SUPERIOR COURT OF DELAWARE, NEW CASTLE, July 9, 2007, Submitted, August 27, 2007, Decided

[/doptab]
[doptab title=”Lawyers”]

If you would like information on how to see the published ratings for different mesothelioma lawyers and law firms, please fill-in the form below:

  • This field is for validation purposes and should be left unchanged.

[/doptab]
[/doptabs]